Depo-Provera and Brain Tumor Risks: What You Need to Know
Depo-Provera is a popular birth control shot that contains medroxyprogesterone acetate, which is injected quarterly to prevent pregnancy. However, recent studies have found that Depo-Provera side effects cause meningioma brain tumors to develop in some women.
The lawyers at Saiontz & Kirk, P.A. are actively investigating Depo-Provera meningioma lawsuits for women throughout the United States, as there is substantial evidence that Pfizer and other drug manufacturers knew or should have known about this risk for decades. Depo-Provera class action lawsuits are also being pursued by users seeking medical monitoring.
Rather than providing accurate warnings about the Depo-Provera brain tumor risks, false and misleading information has been provided to users and the medical community.
Who Qualifies for a Depo-Provera Lawsuit?
Financial compensation may be available through a Depo-Provera meningioma settlement for women who received at least two Depo Subq Provera or Depo-Provera shots and experienced any of the following side effects:
- Intracranial Meningioma
- Benign Brain Tumor
- Malignant Brain Tumor
- Spinal Cord Tumor
There are no fees or expenses unless a settlement or recovery is obtained.
Find out if you qualify for a
DEPO-PROVERA MENINGIOMA LAWSUIT
Index of Depo-Provera Meningioma Side Effect Info On This Page
Does Depo-Provera Cause Meningioma Brain Tumors?
How Depo-Provera May Cause Brain Tumors
Understanding Meningiomas: Types and Symptoms
Depo-Provera Side Effects
Depo-Provera Brain Tumor FAQs
Are there any costs to hire a Depo-Provera Meningioma Lawyer?
Does Depo-Provera Cause Meningioma Brain Tumors?
Yes, side effects of Depo-Provera can increase the risk of developing brain tumors, specifically meningiomas. Several studies have found that long-term use of Depo-Provera, a contraceptive injection containing progestin, significantly heightens the risk of these tumors in certain women.
A groundbreaking study was published in The British Medical Journal (The BMJ) on March 27, 2024, which was led by researcher Noémie Roland, and analyzed data from the French National Health Data System, covering over 108,000 women.
Depo-Provera Meningioma Risks
The researchers found that women using Depo-Provera had a 5.55 times higher risk of developing meningiomas compared to non-users.
Other synthetic progestogens also showed risks:
- Medrogestone: 3.49 times higher risk
- Promegestone: 2.39 times higher risk
On the contrary, non-synthetic progestogens and other birth control options were not found to increase the risk of meningiomas, suggesting that women using Depo-Provera (MPA) face greater risks compared to those using non-synthetic or intrauterine birth control methods.
While the study published primarily focused on the association between Depo-Provera and intracranial meningiomas, it also highlighted that meningiomas can also develop along the spinal cord.
How Depo-Provera May Cause Brain Tumors
Evidence suggests that the synthetic progestin hormone in Depo-Provera contributes to the development of meningiomas, a type of brain tumor, by interacting with progesterone receptors that are highly expressed in these tumors.
Meningiomas are known to be hormone-sensitive, with a significant number of cases showing an overexpression of progesterone receptors (PRs), which play a crucial role in tumor growth and progression.
High Affinity for Progesterone Receptors
Depo-Provera contains medroxyprogesterone acetate (MPA), a synthetic form of progestin that has a high binding affinity to progesterone receptors. Studies indicate that:
- Meningioma cells often exhibit an overabundance of progesterone receptors (PRs), which act as “docking sites” for progestin hormones.
- When MPA binds to these receptors, it stimulates cell proliferation, potentially triggering the growth of existing tumor cells.
- The strong interaction between MPA and PRs can promote the tumor’s ability to thrive in a hormone-rich environment.
Long-Term Depo-Provera Exposure and Hormonal Influence
The risk of developing meningiomas appears to increase with long-term use of Depo-Provera, as prolonged hormonal exposure is known to cause the following side effects:
- Enhances cellular growth signaling: Studies have shown that long-term exposure to progestin can stimulate angiogenesis (new blood vessel formation), providing tumors with the nutrients needed to grow and expand. (Cancer Research).
- Alters gene expression: Progestin can influence genetic pathways involved in cell proliferation, apoptosis (cell death), and DNA repair mechanisms, potentially leading to unchecked tumor growth. (PLOS ONE).
- Hormone-sensitive tissue changes: Prolonged exposure may result in an enlargement of pre-existing tumors or trigger the formation of new meningiomas, especially in patients with other risk factors, such as genetic susceptibility. (The BMJ).
Evidence from observational studies has found that women who receive multiple Depo-Provera injections face an increased risk of meningiomas, particularly with long-term use (5+ years).
Understanding Meningiomas: Types and Symptoms
Meningiomas develop from the meninges, the protective membranes surrounding the brain and spinal cord, which serve to cushion the central nervous system from physical impact and provide a stable environment for neural activity.
A meningioma tumor is composed of cells from the meninges, and typically grows at a slow rate, often forming a dense, encapsulated mass that can press on neural structures, which are essential components of the nervous system involved in transmitting signals throughout the body, regulating vital functions, and ensuring coordination and sensory perception.
This compression of neural structures is why symptoms of a meningioma often include headaches, vision problems, and cognitive changes.
Types of Meningiomas From Depo-Provera Use
Meningiomas are categorized into three grades based on their growth rate and potential for aggressiveness.
- Grade I: Slow-growing and benign (80% of cases)
- Grade II: More aggressive and may recur after treatment
- Grade III: Malignant and fast-growing (rare but serious)
Common Symptoms of Intracranial Meningiomas Include:
- Chronic headaches
- Vision problems
- Cognitive changes, including memory loss
- Seizures
- Motor impairments (weakness, balance issues)
Common Symptoms of Spinal Meningiomas Include:
- Chronic back or neck pain (depending on the tumor’s location).
- Numbness or tingling in the arms or legs.
- Muscle weakness and balance issues.
- Bowel or bladder dysfunction.
- Difficulty walking or paralysis in severe cases.
Depo-Provera Side Effects
Women taking Depo-Provera diagnosed with meningiomas or other brain tumors may face a wide range of secondary effects, which can significantly impact their quality of life. These effects arise due to the tumor’s pressure on the brain and surrounding structures, as well as potential complications from treatment interventions such as surgery or radiation therapy.
Cognitive Decline (Memory Issues, Confusion, Difficulty Concentrating)
Meningioma tumors can exert significant pressure on areas of the brain responsible for cognitive function, leading individuals to experience a range of symptoms including memory loss, difficulty concentrating, and other cognitive impairments.

- Short-term memory loss, making it difficult to remember recent events or conversations.
- Difficulty concentrating, impacting daily activities such as work, reading, and social interactions.
- Mental fatigue, leading to slower thinking and difficulty processing new information.
- Emotional and behavioral changes, such as increased irritability, depression, or anxiety.
Seizures and Neurological Impairment
Depending on the tumor’s size and location, seizures are a common secondary effect of brain tumors associated with Depo-Provera. These seizures can range from mild episodes to severe, life-threatening convulsions.
Types of seizures associated with meningiomas:
- Focal (partial) seizures: Affect specific areas of the brain, leading to symptoms like muscle twitches, sensory disturbances, or localized numbness.
- Generalized seizures: Impact the entire brain, potentially resulting in unconsciousness, loss of bladder control, and severe muscle contractions.
Additionally, tumors can disrupt normal brain function, causing:
- Muscle weakness or paralysis, leading to difficulties with movement and coordination.
- Speech difficulties, such as slurred speech or trouble finding the right words.
- Sensory deficits, including vision impairment, hearing loss, or numbness in the extremities.
Managing seizures often requires medication, but in some cases, surgical intervention may be needed to remove the tumor and reduce pressure on the brain.
Chronic Pain and Mobility Limitations
Meningiomas linked to Depo-Provera may also lead to persistent pain and mobility challenges, affecting an individuals independence and overall well-being.
Common pain-related symptoms include:
- Headaches, often severe and persistent, due to increased intracranial pressure.
- Neck and back pain, especially if the tumor is located near the spinal cord.
- Neuropathic pain, causing burning or tingling sensations in different parts of the body.
Mobility challenges arise due to the tumor’s effects on motor function, leading to:
- Balance and coordination issues, increasing the risk of falls and injuries.
- Muscle weakness, particularly in the arms and legs.
- Difficulty with fine motor skills, such as buttoning clothes or writing.
Physical therapy, pain management strategies, and assistive devices like walkers or canes may be necessary to maintain mobility and independence.
Emotional and Psychological Impact
A Depo-Provera brain tumor diagnosis can have profound emotional and psychological consequences, leading to:
- Depression and anxiety, stemming from the uncertainty of the condition and potential impact on daily life.
- Fear of recurrence, even after successful treatment.
- Social isolation, as individuals may withdraw from friends and family due to physical limitations and emotional distress.
- Cognitive-behavioral changes, such as impulsivity, mood swings, or apathy.
Psychological counseling, support groups, and medications may be recommended to help current or former Depo-Provera users cope with the emotional burden of their condition.
Hormonal Imbalances and Endocrine Disruptions
Since prolonged Depo-Provera use is associated with significant hormonal changes, long-term use and subsequent discontinuation can lead to:
- Irregular menstrual cycles
- Changes in libido
- Weight fluctuations
- Mood disturbances due to hormonal shifts
These hormonal imbalances, combined with brain tumor symptoms, can further complicate a patient’s overall health and recovery process.
Depo-Provera Brain Tumor FAQs
What is Medroxyprogesterone Acetate in Depo-Provera?
Medroxyprogesterone acetate (MPA) is the active ingredient in Depo-Provera, a synthetic form of the hormone progestin used for birth control and hormone therapy. MPA works by preventing ovulation, thickening cervical mucus, and thinning the uterine lining to prevent pregnancy.
However, research has linked long-term use of MPA to an increased risk of developing meningiomas, as it binds strongly to progesterone receptors commonly found in these brain tumors, potentially stimulating their growth.
What are the early signs of a meningioma caused by Depo-Provera?
Early signs of a meningioma from Depo-Provera use can include persistent headaches, blurred vision, loss of balance, and changes in memory or mood. Recognizing these symptoms early is crucial for timely diagnosis and treatment.
What steps should I take if I develop brain tumor symptoms after using Depo-Provera?
If you experience symptoms such as headaches, vision changes, or neurological deficits and have a history of Depo-Provera use, consult with a healthcare professional immediately for an evaluation. If a meningioma is diagnosed, contact Saiontz & Kirk, P.A. for a free consultation to learn more about your rights, and how our lawyers can help.
Who qualifies for a Depo-Provera lawsuit?
Women who received at least two Depo-Provera injections and were later diagnosed with a meningioma tumor of the brain or spine. You do not have to currently be receiving Depo-Provera injections to qualify for a claim.
What compensation can I receive from a Depo-Provera meningioma lawsuit settlement?
You may be entitled to compensation for medical expenses, including future medical monitoring, lost wages, and pain and suffering. Depo-Provera meningioma settlements may also cover other losses directly related to your diagnosis, such as long-term care needs.
Is there a deadline to file a Depo-Provera brain tumor lawsuit?
Yes, deadlines to file a lawsuit vary, as each state has its own statutes of limitations. It is crucial to consult with a Depo-Provera lawyer to understand the specific timeline for your case and ensure it is filed on time to protect your legal rights.
Are there any costs to hire a Depo-Provera Meningioma Lawyer?
There are absolutely no out-of-pocket costs to review your case or hire our attorneys. Depo-Provera meningioma claims are evaluated by our lawyers for individuals throughout the United States, and all cases are handled on a contingency fee basis.
Through the use of contingency attorney fees, individuals have access to the experience and resources of our national law firm for Depo-Provera meningioma lawsuit settlement — regardless of their individual financial resources.
You pay nothing up front to hire our Depo-Provera meningioma lawyers, and we only receive an attorney fee or expenses out of the money that is obtained from the manufacturers. Our law firm receives nothing unless we win your case!
What are the steps in a Depo-Provera case evaluation?
Complete Our Case Evaluation Request Form. Providing contact information and some information about your Depo-Provera case.
Get Contacted by Saiontz & Kirk, P.A. You will be contacted by our law firm to help determine if financial compensation may be available for you and your family.
You Decide If You Want to Move Forward. If our lawyers determine that we can help with your case then you decide whether to move forward and hire us to pursue compensation.
FIND OUT IF YOU QUALIFY FOR A DEPO-PROVERA MENINGIOMA SETTLEMENT